Ommio Health, Inc.
Biotechnology company developing therapeutics and delivery platforms using a proprietary chemistry platform derived from natural molecular scaffolds. Focus areas include development of active pharmaceutical ingredients (APIs), drug-delivery solutions emphasizing increased stability, targeted/controlled release and enhanced bioavailability, and polymeric therapeutic biomaterials. Initial therapeutic indications include non-addictive pain relief, sleep disorders, weight/metabolism management, and anxiety, with parallel veterinary development programs.
Industries
N/A
Products
APIs targeting non-addictive pain relief (preclinical)
Active pharmaceutical ingredient programs focused on non-addictive approaches to pain cessation (programs in development).
Therapeutic candidates for sleep, weight/metabolism, and anxiety (preclinical)
Programs applying the proprietary platform to indications including sleep disorders, weight and metabolism management, and anxiety relief.
Polymeric therapeutic biomaterials
Bioactive polymeric structures derived from platform chemistry intended for therapeutic biomaterials applications.
APIs targeting non-addictive pain relief (preclinical)
Active pharmaceutical ingredient programs focused on non-addictive approaches to pain cessation (programs in development).
Therapeutic candidates for sleep, weight/metabolism, and anxiety (preclinical)
Programs applying the proprietary platform to indications including sleep disorders, weight and metabolism management, and anxiety relief.
Polymeric therapeutic biomaterials
Bioactive polymeric structures derived from platform chemistry intended for therapeutic biomaterials applications.
Services
Collaborative R&D partnerships for therapeutic and delivery development
Collaborative development engagements for APIs, delivery platforms, and polymeric biomaterials across human and veterinary applications.
Collaborative R&D partnerships for therapeutic and delivery development
Collaborative development engagements for APIs, delivery platforms, and polymeric biomaterials across human and veterinary applications.
Expertise Areas
- Therapeutic discovery and development
- Drug delivery platform development
- Medicinal and natural product chemistry
- Polymeric biomaterials
Key Technologies
- Natural product–derived therapeutic scaffolds
- Controlled and targeted drug delivery
- Polymeric therapeutic biomaterials
- Medicinal chemistry